Interferon type I responses in primary and secondary infections

被引:52
作者
Alsharifi, Mohammed [1 ]
Muellbacher, Arno [1 ]
Regner, Matthias [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 0200, Australia
关键词
type I interferon; immunoregulation; viral infections;
D O I
10.1038/sj.icb.7100159
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian host responds to a microbial infection with a rapid innate immune reaction that is dominated by type I interferon (IFN-I) release. Most cells of vertebrates can respond to microbial attack with IFN-I production, but the cell type responsible for most of the systemic IFN-I release is thought to be plasmacytoid dendritic cells (pDCs). Besides its antimicrobial and especially anti-viral properties IFN-I also exerts a regulatory role on many facets of the sequential adaptive immune response. One of these is being the recently described partial, systemic activation of the vast majority of B and T lymphocytes in mice, irrespective of antigen reactivity. The biological significance of this partial activation of lymphocytes is at present speculative. Secondary infections occurring within a short time span of a primary infection fail to elicit a similar lymphocyte activation response due to a refractory period in systemic IFN-I production. This period of exhaustion in IFN-I responses is associated with an increased susceptibility of the host to secondary infections. The latter correlates with well-established clinical observations of heightened susceptibility of patients to secondary microbial infections after viral episodes.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 127 条
[41]   Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling [J].
Hahm, B ;
Trifilo, MJ ;
Zuniga, EI ;
Oldstone, MBA .
IMMUNITY, 2005, 22 (02) :247-257
[42]   Fratricide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I [J].
Hanon, E ;
Stinchcombe, JC ;
Saito, M ;
Asquith, BE ;
Taylor, GP ;
Tanaka, Y ;
Weber, JN ;
Griffiths, GM ;
Bangham, CRM .
IMMUNITY, 2000, 13 (05) :657-664
[43]   Characterization of the type I interferon locus and identification of novel genes [J].
Hardy, MP ;
Owczarek, CM ;
Jermiin, LS ;
Ejdebäck, M ;
Hertzog, PJ .
GENOMICS, 2004, 84 (02) :331-345
[44]   Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis [J].
Hattori, H ;
Okano, M ;
Yoshino, T ;
Akagi, T ;
Nakayama, E ;
Saito, C ;
Satoskar, AR ;
Ogawa, T ;
Azuma, M ;
Nishizaki, K .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (08) :1242-1249
[45]   NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy [J].
Hayakawa, Y ;
Screpanti, V ;
Yagita, H ;
Grandien, A ;
Ljunggren, HG ;
Smyth, MJ ;
Chambers, BJ .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :123-129
[46]   Species-specific regulation of Toll-like receptor 3 genes in men and mice [J].
Heinz, S ;
Haehnel, V ;
Karaghiosoff, M ;
Schwarzfischer, L ;
Müller, M ;
Krause, SW ;
Rehli, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :21502-21509
[47]   Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection [J].
Honda, K ;
Sakaguchi, S ;
Nakajima, C ;
Watanabe, A ;
Yanai, H ;
Matsumoto, M ;
Ohteki, T ;
Kaisho, T ;
Takaoka, A ;
Akira, S ;
Seya, T ;
Taniguchi, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10872-10877
[48]   VIRUS INTERFERENCE .1. THE INTERFERON [J].
ISAACS, A ;
LINDENMANN, J .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927) :258-267
[49]   THE INTERFERON SYSTEM - A REVIEW WITH EMPHASIS ON THE ROLE OF PKR IN GROWTH-CONTROL [J].
JARAMILLO, ML ;
ABRAHAM, N ;
BELL, JC .
CANCER INVESTIGATION, 1995, 13 (03) :327-338
[50]  
Jeannin P, 1999, J IMMUNOL, V162, P2044